OmicEra is a leading proteomics and artificial intelligence (AI) startup, dedicated to revolutionizing medical diagnostics through advanced technologies. The company focuses on leveraging AI to enhance proteomic analysis, aiming to improve patient outcomes and streamline healthcare processes.
On November 25, 2025, Leo International Precision Health Aktiengesellschaft announced a significant capital increase. The decision, sanctioned by both the Executive Management and Supervisory Boards, aims to bolster the company's financial standing by issuing 50,000 new shares without subscription rights.
The picturesque town of Planegg, nestled near Munich, finds itself at the heart of a technological revolution with the inauguration of the Sports Intelligence Hub. This initiative promises to enhance the global sports industry through advanced AI technologies, aligning with Planegg's growing reputation as a hub for innovation.
Atlantik Elektronik GmbH, a leading technology marketer based in Planegg, has announced the launch of the Lantronix Open-Qâ„¢ 8550CS Development Kit. This state-of-the-art kit is designed to support advanced edge AI applications and showcases the company's commitment to innovation.